Mối tương quan giữa hoạt động ức chế của các chất chẹn canxi đối với sự co thắt cơ trơn mạch máu in vitro sau khi khử cực K+ và in vivo sau khi kích thích α2-adrenoceptor

Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606–718 Diem K, Lentner C (1970) In: Diem K, Lentner C (eds) Statistical methods. Documenta Geigy. Basel, Geigy, pp 174–183 Draper NR, Smith H (1966) Applied regression analysis. Wiley, New York Fleckenstein A, Fleckenstein-Grün G, Byon YK, Haastert HP, Spah F (1979) Vergleichende Untersuchungen über die Ca2+-antagonistischen Grundwirkungen von Niludipin (Bay a 7168) und Nifedipin (Bay a 1040) auf Myocard, Myometrium und glatten Gefäßmuskulatur. Arzneimittelforsch 29:230–246 Fleckenstein-Grün G, Fleckenstein A (1980) Calcium-Antagonismus, ein Grundprinzip der Vasodilatation. In: Fleckenstein A, Roskamm H (eds) Calcium antagonismus. Springer, Berlin Heidelberg New York, pp 191–207 Godfraind T, Kaba A (1972) The role of calcium in the action of drugs on vascular smooth muscle. Arch Int Pharmacodyn 196:35–49 Grün G, Fleckenstein A (1972) Die elektromechanische Entkoppelung der glatten Gefäßmuskulatur als Grundprinzip der Coronardilatation durch 4-(2′-Nitrophenyl)2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäure-dimethylester (BAY a 1040, Nifedipine). Arzneimittelforsch 22:334–344 Haeusler G (1972) Differential effect of verapamil on excitation-contraction coupling in smooth muscle and excitation-secretion coupling in adrenergic nerve terminals. J Pharmacol Exp Ther 180:672–682 Ishii H, Itoh K, Nose T (1980) Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats. Eur J Pharmacol 64:21–29 Kazda S, Garthoff B, Meyer H, Schlossman K, Stoepel K, Towart R, Vater W, Wehinger E (1980) Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). Arzneimittelforsch 30:2144–2162 Knorr A, Stoepel K (1981) Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestraint dogs. Arzneimittelforsch 31:2062–2064 Kobinger W, Pichler L (1980) Investigation into different types of post- and presynaptic α-adrenoceptors at cardiovascular sites in rat. Eur J Pharmacol 65:393–402 Kondo K, Suzuki H, Okuno T, Suda M, Saruto T (1980) Effects of nifedipine, diltiazem and verapamil on the vasoconstrictor responses to epinephrine and potassium ions in the rat mesenteric artery. Arch Int Pharmacodyn 245:211–217 Lederballe Pedersen O, Christensen NJ, Rämsch KD (1980) Comparison of acute effects of nifedipine in normotensive and hypertensive man. J Cardiovasc Pharmacol 2:357–366 Massingham R (1973) A study of compounds which inhibit vascular smooth muscle contraction. Eur J Pharmacol 22:75–82 Olivari MT, Bartorelli C, Polese A, Fiorentini C, Moruzzi P, Guazzi MD (1979) Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation 59:1056–1062 Schümann HJ, Görlitz BD, Wagner J (1975) Influence of papaverine D 600 and nifedipine on the effects of noradrenaline and calcium on the isolated aorta and mesenteric artery of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 289:409–418 Thorens S, Haeusler G (1979) Effects of some vasodilators on calcium translocation in intact and fractionated vascular smooth muscle. Eur J Pharmacol 54:79–91 Thuillez C, Giudicelli JF (1981) Pharmacologie cardio-vasculaire des antagonistes du calcium. Thérapie 36:107–121 Timmermans PBMWM (1981) Calcium antagonism and α2-adrenoceptor activation. Naunyn-Schmiedeberg's Arch Pharmacol 316 (Suppl): R57 Towart R (1981) The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium antagonistic dihydropyridines. Circ Res 48:650–657 Towart R, Stoepel K (1979) The vascular mechanisms of action of Bay e 5009, a new calcium antagonist with a potent, antihypertensive action. Naunyn-Schmiedeberg's Arch Pharmacol 308 (Suppl): R18 Van Meel JCA, De Jonge A, Wilffert B, Kalkman HO, Timmermans PBMWM, Van Zwieten PA (1981a) Vascular smooth muscle contraction initiated by postsynaptic α2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol 69:205–208 Van Meel JCA, De Jonge A, Kalkman HO, Wilffert B, Timmermans PBMWM, Van Zwieten PA (1981b) Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic α2-adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 316:288–293 Van Meel JCA, De Jonge A, Timmermans PBMWM, Van Zwieten PA (1981c) Selectivity of some alpha-adrenoceptor agonists for peripheral alpha1- and alpha2-adrenoceptors in the normotensive rat. J Pharmacol Exp Ther 219:260–267 Van Meel JCA, De Zoeten K, Timmermans PBMWM, Van Zwieten PA (1982) Impairment by nifedipine of vasopressor responses to stimulation of postsynaptic α2-adrenoceptor in ganglion-blocked rabbits. Further evidence for the selective inhibition of postsynaptic α2-adrenoceptor induced pressor responses by calcium antagonists. J Auton Pharmacol 2:13–20 Van Nueten JM, Van Beek J, Janssen PAJ (1978a) Effect of flunarizine on calcium-induced responses of peripheral vascular smooth muscle. Arch Int Pharmacodyn 232:42–52 Van Nueten JM, Van Beek J, Janssen PAJ (1978b) The vascular effects of flunarizine as compared with those of other clinically used vasoactive substances. Arzneimittelforsch 28:2082–2087 Van Rossum JM (1963) Cumulative dose-response curves. Arch Int Pharmacodyn 143:299–330 Van Zwieten PA, Van Meel JCA, De Jonge A, Wilffert B, Timmermans PBMWM (1982) Central and peripheral α-adrenoceptors. J Cardiovasc Pharmacol 4:19–24 Zsóter TT (1980) Calcium antagonists. Am Heart J 99:805–810